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ABSTRACT 
Background 
The aim of the present study was to assess the efficacy of a ready-to-use injectable bone 
substitute for bone regeneration around dental implants placed into fresh extraction sockets. 
Methods 
Third and fourth mandibular premolars were extracted from 3 Beagle dogs and the 
interradicular septa were surgically reduced to induce a mesial bone defect. Thereafter, 
immediate placements of titanium implants were performed. On the left side of the jaw, 
mesial bone defects were filled with an injectable bone substitute (IBS), obtained by 
combining a polymer and a biphasic calcium phosphate ceramic. As a control, the right 
defects were left unfilled. After 3 months of healing, specimens were prepared for histological 
and histomorphometric evaluations. 
Results 
No post surgical complication was observed during the healing period. In all experimental 
conditions, histological observations revealed a lamellar bone formation in contact with the 
implant. Histomorphometric analysis showed that IBS triggers a significant (p<0.05) increase 
in term of thread numbers in contact with bone (TN), bone-to-implant contact (BIC) and peri-
implant bone density (PBD), of about 8.6%, 11.0% and 14.7%, respectively. In addition, no 
significant difference was observed when TN, BIC and PBD in filled defects were compared 
to no-defect sites. 
Conclusion 
It is concluded that an injectable bone substitute composed of a polymeric carrier and calcium 
phosphate significantly increase bone regeneration around immediate implants. 
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INTRODUCTION 
 
Delayed placement of dental implants after alveolar healing is a proven and aesthetic 
technique, but requires an extended time treatment before patients can enjoy the final result.1,2 
Immediate implantation after tooth extraction is an attractive alternative that presents several 
advantages such as reduction of post-extraction resorption, optimal positioning of the implant 
and reduction of the time required for prosthetic rehabilitation.3,4 However, the discrepancy 
between the transversal diameter of the socket (conical) and of the implant (cylindrical) 
frequently generates a gap between the bony walls of the socket and the implant.5 In large 
bony defects, this void can be colonised by epithelial cells, which induces fibrointegration and 
then implant failure.6,7 Therefore, guided bone regeneration (GBR) alone or in association 
with bone replacement graft has been developed and currently gives satisfactory results to 
achieve implant osseointegration.7-9 Nevertheless, an early exposure of the barrier membrane 
may promote secondary infections and consequently delay the peri-implant bone 
regeneration.10,11 Rotated full thickness flaps were suggested as an alternative to GBR, but 
vestibular flaps were often a source of aesthetical problems and palatal flaps may provoke 
pain on exposed bone.12,13 
Among the available materials used for pre-implant bone reconstruction, autologous bone is 
currently the gold-standard because it is a source of osseous matrix, cells, and growth 
modulating molecules.14 However, it requires the graft to be harvested at a distance from the 
operation site, which makes the initial operation more complicated. To overcome the 
autograft limits, many substitution biomaterials have been proposed. Materials of human and 
animal origin have the disadvantages of limited supply and potential risk of cross 
contamination.15,16 Consequently, synthetic products were developed.17 For example, biphasic 
calcium phosphate (BCP), an intimate mixture of hydroxyapatite (HA) and ß-tricalcium 
	 
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phosphate (ß-TCP).18 BCP offers the potential for bone reconstruction since it has a chemical 
composition close to biologic bone apatites19 and has already proven its efficacy as a bone 
substitute material in many human clinical applications.20-24 More recently, the association of 
BCP granules to a polymeric gel has provided a ready-to-use injectable bone substitute 
material (IBS).25,26 Previous animal studies conducted in our laboratory have shown the 
biocompatibility and the osteoconductive property of IBS.27-29 We have also demonstrated in 
a preliminary study the IBS biofunctionality when used as socket filler in dogs.30 
The aim of the present study was to assess the IBS influence on bone regeneration around 
titanium dental implants immediately placed after tooth extraction without using an 
osteopromotive membrane technique. A comparative histomorphometric study was performed 
on peri-implant bone defects. Defects were treated by IBS filling and the control defects were 
left unfilled to observe a physiological healing process. 
 
MATERIALS AND METHODS 
Injectable Bone Substi tute 
The biomaterial used in this study was a composite combining a polymer and a calcium 
phosphate mineral phase.31 
Mineral phase 
The ceramic composed of BCP granules with a 60/40 HA/ß-TCP weight ratio was obtained 
by hydrolysis of a commercial dicalcium phosphate dihydrate. The resulting apatite powders 
were granulated and sifted to select only granules with a 40 to 80 µm diameter. After sintering 
at 1,150°C to form BCP, the granules were placed on a 40 µm sifter to eliminate the smallest 
particles. 
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Polymeric phase 
As previously described,25 the associated polymer was a cellulose derivative (methyl-
hydroxy-propyl-cellulose = MHPC) previously proposed as an efficient vehicle for the 
mineral phase.32 Briefly, a solution of 3% MPHC was prepared by dissolving raw dry MPHC 
powder§ in double distilled water with stirring for 48 hours. 
§
 E4M PREMIUM EP, Colorcon, Bougival, France 
Composite 
The composite biomaterial, obtained by mixing a 3% MPHC solution with the 40 to 80 µm 
BCP granules in a 50/50 weight ratio, was placed in ready-to-use plastic injectors and 
sterilized by steam at 121°C for 20 minutes. This process preserves the gel consistency of the 
polymer and decreases viscosity only very slightly.30 
 
Animal experiments 
The three 4-year-old female adult Beagle dogs used were bred exclusively for biomedical 
studies and kept at the National Veterinary School of Nantes according to European 
Community guidelines for the care and the use of laboratory animals (DE 86/609/CEE). 
Gingival health was checked before experimentation, and teeth were scaled and polished 
under general anaesthesia. Antibiotic treatment with spiramycin and metronidazole was 
given for 5 days. 
Stomorgyl, Rhône-Mérieux, Lyon, France 
 
Surgical procedures 
All surgical procedures were performed under general anaesthesia with intravenous sodium 
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thiopental¶ (12.5 mg/kg) followed by volatile anaesthesia with halothane. During surgery, 
animals received 1 g of cephalosporin antibiotic# perfused intravenously. Implant placements 
were performed on right and left third and fourth mandibular premolars (fig. 1-a). 
Gingival incisions were performed mesially from the first premolar and distally to the molar 
teeth. Then, full-thickness buccal and lingual flaps were raised. After vertical interradicular 
section, each root was carefully elavated and then gently extracted. 
Distal sockets were then drilled following the basic surgical principles governing the 
placement of ITI dental implants.33 Thereafter, the interradicular septa were resected with a 
mini-rongeur Friedman to create a mesial bone defect adjacent to the mesial socket on a 6 mm 
height, 4 mm in the bucco-lingual direction and 5 mm in the mesio-distal direction (fig. 1-b). 
After a complete alveolar cleaning, solid cylindrical screw implants** were manually inserted 
in the implant beds (fig. 1-c). Specifications of ITI implants included a 3.3 mm diameter, an 8 
mm length and a titanium plasma spray (TPS) coating. The primary stability was assessed and 
implants were covered with 1.5 mm closure screws. On the left side, mesial sockets were 
filled with IBS injection from the bottom to the top of the defect (fig. 1-c) in direct contact 
with the implant (fig. 1-d). On the right side, implants were placed following the same 
procedure but without IBS. The muccoperiosteal flaps were then sutured with an interrupted 
non-absorbent suture†† (fig. 1-e). 
Antibiotic treatment by intramuscular injection of cephalosporin (15 mg/kg, b.i.d.) was 
continued for 48 hours after surgery. Animals were checked daily and fed with a soft diet. 
Sutures were removed under short general anaesthesia 3 weeks later (day 21), and a normal 
diet was then given. The animals were sacrificed 3 months after implantation (day 91) by 
intravenous injection of overdosed sodium pentobarbital‡‡. 
¶
 Nesdonal, Rhône-Mérieux 
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#
 Cefaloject, Bristol Laboratories, Paris, France 
**
 ITI Esthetic plus, Straumann AG Institute, Waldenburg, Switzerland 
††
 Silk black braided, PRED, Paris, France 
‡‡
 Doléthal, Vétoquinol laboratory, Lure, France 
Sample preparation 
Bone segments were immediately dissected from animals with a diamond disk and fixed in a 
4% paraformaldehyde solution buffered with phosphate buffered saline (PBS; pH 7.2). Each 
sample was then dehydrated by successive immersion in graded ethanol for 24 hours at 4°C 
(80°, 95°, 100°) and acetone (1 day). Thereafter, specimen were infiltrated with a 
glycolmethylmetacrylate resin (GMMA) at -20°C for 8 days (repeated twice). Finally, 
samples were embedded in GMMA (4 days, 4 °C). 
 
Histological evaluation 
Both filled and unfilled sites were histologically evaluated with light§§ and scanning 
electron microscopy (SEM). For each sample, 10 µm thick sections were cut with a 
diamond microtome saw¶¶ along to the long axis of implants in a mesiodistal direction and 
then stained with Movat pentachrome for light microscope observation. Then, three 500 µm 
sections were isolated from each sample and both surfaces were prepared by sputtering with 
gold-palladium## for SEM observations at 20 kV. 
§§
 Axioplan 2, Zeiss, Jena, Germany 
 
 JSM 6300, Jeol, Tokyo, Japan 
¶¶
 MS 1600, Leitz, Westlar, Germany 
H
AL author m
anuscript    inserm
-00176539, version 1
 9 
##
 AE1230, EMScope, Ashford, UK 
 
Histomorphometric studies 
For quantitative evaluation of bone regeneration, 500 µm sections prepared as described 
above were observed with SEM apparatus coupled to a semi-automatic image analyser***. 
With image analysis, three parameters were measured in mesial bone defects and distal sites: 
- The number of threads in contact with bone in relation to the total number of threads (TN), 
- The Bone-to-Implant Contact (BIC) with a percentage ratio studied at two different heights: 
. the endosseous part of the implant (EH) 
. a 3 mm cervical height limited to the bone defects (DH), 
- The Peri-implant-Bone-Density (PBD) inside DH on 3 zones at a 0.5 mm thickness: 
. zone a : from the implant surface to 0.5 mm, 
. zone b : from 0.51 to 1 mm, 
. zone c : from 1.1 to 1.5 mm. 
***
 Quantimeter 500, Leica, Cambridge, UK 
 
X-ray micro-analysis 
Sample sections (500 µm thick) were polished in order to eliminate gold-palladium and were 
sputter coated with carbon†††. Then, a quantitative X-ray micro-analysis was performed with 
Energy Dispersive System (EDS)‡‡‡. Calcium (Ca), phosphate (P), magnesium (Mg), and 
sodium (Na) values were measured at four different locations with regard to bone defects 
(IBS filled and unfilled), alveolar bone (in implant proximity) and basal bone. 
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†††
 JEE-4B, Jeol 
‡‡‡
 EXL II, Oxford instruments, London, UK 
 
Statistical analysis 
Results were expressed as mean (± SEM). Comparative study of means of the 16 filled sites, 
the 18 unfilled sites and the 34 distal sites were performed using one way analysis of variance 
(ANOVA) followed by a post-hoc test (Fischer’s projected least significant differences) with 
a statistical significance at p<0.05. 
 
RESULTS 
Clinical results 
No post surgical complication or infection was observed during the healing period. Sutures 
were removed after three weeks. After one month, the closure screws initially covered by 
muccoperiosteal flaps were exposed with excellent peri-implant soft tissue conditions (fig. 2). 
At the time of euthanasia, all implants seemed to be clinically osseointegrated and none 
presented with mobility. 
 
Histological results 
Light microscopy observations (magnification x 50) showed homogeneous bone healing in all 
tested conditions (fig. 3). A bone-to-implant contact was observed on all the distal threads and 
on most mesial threads in filled defects. An exposure of the first or the second thread was 
observed in five unfilled defects. Higher magnification (x200) confirmed the close contacts 
between lamellar bone and implant TPS surface (fig. 4). As previously described34, in the 
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filled defects (fig. 4a), BCP granules were not visible and bone tissue showed the same 
histological characteristics observed in the distal sites (fig. 4b). For all implants, junctional 
epithelium was closely adapted to the machined smooth neck of the implant. 
SEM showed new bone formation more homogenous and dense in the filled sites (fig. 5a) as 
compare to the unfilled sites (fig. 5b). Large unmineralised areas were observed in absence of 
IBS (fig. 6b), whereas bone tissue occupied a large extent of the filled sites (fig. 6a). 
 
Quantitative evaluation 
For all distal sites, threads were always in contact with bone surface. On the contrary, TN was 
always lower in mesial bone defects. However, in mesial bone defects, TN remained always 
significantly (p<0.01) higher in the presence of IBS as compare to the unfilled defect (fig. 7) 
(98.44% ±1.52 and 92.78% ±2.98 respectively). 
For EH, BIC in filled defects showed a significant (p<0.01) increase when compared with the 
unfilled defects (54.54% ±1.29 and 46.67% ±1.08 respectively). In addition, a significant 
augmentation of BIC in DH was observed in filled sites (48.86% ±1.97 vs 37.60% ±1.58 in 
unfilled defects). Interestingly, BIC was not significantly different between the filled mesial 
sites and the distal sites (fig. 8). 
In all sites, PBD was always significantly lower for the zone close to the implant (zone a) as 
compared to the zones located at a distance (zones b and c). No significant difference was 
observed in zone b and zone c. Whatever the studied zone, minor PBD was obtained in 
unfilled defects. IBS induced a significant (p<0.01) increase of PBD in zone a, b and c: 
58.68% ±2.32 vs 44.5% ±1.76; 60.1% ±1.48 vs 48.46% ±1.51 and 61.71% ±0.85 vs 48.21% 
±1.68 respectively. Furthermore, there was no significant difference between PBD values in 
mesial filled sites and those of distal sites (fig. 9). 
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The atomic composition of the analysed samples in EDS showed no significant difference 
with respect to the studied locations. All the measurements in the implant peripheries were 
very close to basal bone values. Calcium and phosphate values were respectively of 23.29% 
±1.95 and 13.81% ±0.96 in filled bone defects. Magnesium and sodium represented less than 
1% of the total elements. Ca/P ratio showed very little variation (from 1.66 ±0.03 for basal 
bone to 1.70 ±0.07 in distal sites). In the filled and unfilled defects, this ratio was similar 
(1.68 ±0.04 with IBS and 1.68 ±0.06 without IBS). 
 
DISCUSSION 
 
To our knowledge, this study demonstrates for the first time that the use of an injectable bone 
substitute, composed of a calcium phosphate ceramic and a polymeric carrier, promotes bone 
regeneration around dental implants immediately placed into fresh extractions sockets. 
Cortical and trabecular bone grafts are the materials of choice for pre-implant surgery. Among 
the biomaterials proposed as an alternative to bone autografts, calcium phosphate (CaP) 
ceramics such as hydroxyapatite (HA), beta-tricalcium phosphate (ß-TCP) and the HA/ß-TCP 
association [termed biphasic calcium phosphate (BCP)] have been used successfully because 
their chemical composition is closely related to that of bone mineral.19 Within the past few 
years, a proposed ready-to-use injectable bone substitute (IBS) has been developed. IBS is an 
association of BCP granules with a cellulosic hydrogel.25 Our laboratory has previously 
demonstrated the osteoconductive potential of this innovative biomaterial in an alveolar bone 
site.30,35 
In contrast to the delayed implantation protocol, immediate implant placement presents 
numerous advantages including prevention of alveolar bone resorption and reduction of 
rehabilitation time.3,4 Nevertheless, the success rate of both methods remains similar when 
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primary stability of implants is associated with an osteopromotive technique.36,37 To favour 
bone healing in cases where there are wide gaps between implant surfaces and sockets walls, 
guided bone regeneration (GBR), alone or in association with bone substitute materials, has 
been investigated with satisfactory but variable results.5,10 In an attempt to propose an 
alternative to occlusive barrier membranes, the present work investigates the efficiency of IBS 
to promote bone regeneration around solid-screw implants placed immediately after tooth 
extraction. 
Immediate implantation in dogs has displayed variable failure rates.10,38 The present study has 
shown no implant mobility and no implant failure. This clinical success rate is comparable to 
that obtained with delayed implants placed after a 3 month healing period.39 Several 
hypotheses may explain these encouraging results: atraumatic extraction with respect to 
alveolar walls; no bone heating during the defect creation thanks to the manual rongeur; 
implant primary stability through preservation of vestibular and lingual processes; 
postoperative soft diet to reduce mastication forces and daily postoperative observation to 
prevent gingival inflammation. 
To strengthen our clinical data, we conducted histological examinations of peri-implant 
tissues regeneration. SEM and light microscopic observations showed mucosa, osteoid and 
mineralised lamellar bone, but no residual BCP particles despite high magnification, as 
previously reported.34 Furthermore, EDS demonstrated that newly-formed bone presents the 
same Ca and P values as well as Ca/P ratio with regards to basal bone. Thus, IBS confirmed 
his osteoconductive potential previously demonstrated.30,35 Nevertheless, the lack of 
information during intermediary intervals did not permit evaluation of the biomaterial 
transformation kinetics, which however seemed to be compatible with healing periods 
currently recommended for immediate implantation.5,40 
Numerous unmineralised areas were observed in unfilled defects witch suggest a delay in 
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bone healing. However, partial bone regeneration was observed in these sites. In filled sites, 
bone regeneration showed the same histological characteristics as compared to no-defect sites. 
Interestingly, the absence of fibrous interposition in filled defects strongly suggest that IBS 
may represent an occlusive barrier against epithelial cell colonisation. 
The main objective of this work was to obtain reliable quantitative assessment of the different 
parameters of bone regeneration: the number of osseointegrated threads (TN), the rate of 
bone-to-implant contact (BIC), and the peri-implant bone density (PBD). Among the 
numerous available tools, we focused on semi-automatic image analysis because it permits 
quick and accurate analysis of a large amount of information.41,42 Previous 
histomorphometrical studies, dedicated to implant osseointegration in animals, have mostly 
been restricted to BIC evaluation.43,44 In order to further evaluate the bone regeneration 
process beyond the bone/implant interface, image analysis was also conducted on PBD at 
various distances from the implant surface. 
A centripetal bone regeneration from the alveolar walls is even observed in unfilled sites 
because experimental defects were not critical-size defects.30 However, all quantitative data 
remains lower in unfilled defects. In addition, TN, BIC and PBD in filled defects 
demonstrated no significant difference as compared to the no-defect sites. Since the 
quantitative results in IBS-treated sites are higher or equal to the values reported with 
immediate implantation in dog,10,44-47 IBS appears to satisfy immediate implantation 
requirements. 
 
CONCLUSION 
 
This study demonstrates that our injectable bone substitute (IBS), a composite biomaterial, 
promotes bone regeneration around implants immediately placed after tooth extraction. 
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Therefore, it seems conceivable that IBS could be an alternative to autologous grafts or GBR 
alone or in association with bone substitute biomaterial. However, these promising results are 
to be confirmed by further biomechanical studies after implant loading, pull out tests and by 
evaluation of reverse torque. IBS could be further propose for clinical applications such as 
socket filling for ridge preservation, pre-implant reconstruction of osseous deficiencies or 
sinus floor elevations. 
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ILLUSTRATION LEGENDS 
 
Figure 1: Photographs of the surgical procedures. 
a: third (P3) and fourth (P4) left mandibular premolar (preoperative view), 
b: mesial socket after extraction (MS), interadicular septum resection (SR), distal socket 
preparation (DS) in P3 and mesial bone defect (MS + SR) probing in P4, 
c: implants (ITI) placed in distal socket of P3 before filling with IBS and IBS injection in 
mesial bone defect of P4, 
d: 2 implants placed in distal sockets and non-overpacked fill with IBS, 
e: overlapping flap sutures. 
 
Figure 2: Photograph one month after surgery. Note the soft tissues healing around closure 
screws emergence. 
 
Figure 3: Light microscopy observation of an axial section of implant after three months of 
healing with IBS. Note the homogeneous bone healing around implant. 
(Movat pentachrome, original magnification x 50). 
 
Figure 4: Light microscopy observations of the first cervical thread of implants after three 
months of healing. Note different bone regenerations at the implant contact. 
a: mesial defect filled by IBS, 
b: distal site without defect, 
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c: mesial defect unfilled by IBS. 
(Movat pentachrome, original magnification x 200). 
 
Figure 5: Scanning electron microscopy observations of axial sections of implants after three 
months of healing.  
a: mesial filled defect (left) and distal site (right). Note the presence of an homogeneous bone 
ingrowth in the filled defect when compared with distal site, 
b: unfilled mesial defect (left) and distal site (right). Note the presence of decreased bone 
regeneration in mesial unfilled defect when compared with distal site. 
(bar = 1 mm). 
 
Figure 6: Scanning electron microscopy observations of the cervical threads of implants after 
three months of healing. 
a: filled defect. Note the close contact between bone and TPS surface 
b: unfilled defect. Note the presence of large unmineralised areas 
(bar = 0.2 mm). 
 
Figure 7: Threads of implants in contact with bone after three months of defect healing either 
in sites filled (defects + IBS) or unfilled (unfilled defects) with IBS. As a control, distal sites 
were left without bone defects (no-defect). Results are expressed in percentage (± SEM) of 
threads not in contact with bone. 
* : p < 0.01 compared with the unfilled defects. 
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Figure 8: Bone-to-implant contact in endo-osseous height of implants (EH) and in bone defect 
height (DH) after three months of defect healing either in sites filled (filled defects) or 
unfilled (unfilled defects) with IBS. As a control, distal sites were left without bone defects 
(no-defect). Results are expressed in height percentage (± SEM). 
*: p < 0.01 compared with the unfilled defects. 
NS: no significant 
 
 
Fig. 9: Peri-implant bone density of 3 various zones after three months of defect healing either 
in sites filled (filled defects) or unfilled (unfilled defects) with IBS. As a control, distal sites 
were left without bone defects (no-defect). As described in materials and methods, zone a was 
from TPS surface to 0.5 mm, zone b, from 0.51 to 1 mm, zone c, from 1.1 to 1.5 mm. Results 
are expressed as percentage (± SEM) of total surface in each zone. 
* : p < 0.01 compared with the unfilled defects. 
NS: no significant 
Fig 1a 
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